Evidence map›Paper›PMID 36523783›Full record

SynthesisFrontiers in medicine2022

Costs and effects of telerehabilitation in neurological and cardiological diseases: A systematic review.

Rocio Del Pino, Maria Díez-Cirarda, Iker Ustarroz-Aguirre, Susana Gonzalez-Larragan, Massimo Caprino, Stefan Busnatu, Kai Gand, Hannes Schlieter, Iñigo Gabilondo, Juan Carlos Gómez-Esteban

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
6.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. The Safety of Telerehabilitation: Systematic Review.JMIR rehabilitation and assistive technologies · 2025
    Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Rocio Del PinoNeurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
Maria Díez-CirardaNeurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
Iker Ustarroz-AguirreEconomic Evaluation Department, Cruces University Hospital, Barakaldo, Spain.
Susana Gonzalez-LarraganDepartment of Health Science Library, Cruces University Hospital, Barakaldo, Spain.
Massimo CaprinoDepartment of Neurorehabilitation Sciences, Casa di Cura del Policlinico Spa, Milano, Italy.
Stefan BusnatuFaculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
Kai GandTechnische Universität Dresden, Faculty of Business and Economics, Research Group Digital Health, Dresden, Germany.
Hannes SchlieterTechnische Universität Dresden, Faculty of Business and Economics, Research Group Digital Health, Dresden, Germany.
Iñigo GabilondoNeurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
Juan Carlos Gómez-EstebanNeurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
BioCruces Health research Institute · ESHospital de Cruces · ESTechnische Universität Dresden · DECarol Davila University of Medicine and Pharmacy · ROUniversity of the Basque Country · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Telerehabilitation in neurological and cardiological diseases is an alternative rehabilitation that improves the quality of life and health conditions of patients and enhances the accessibility to health care. However, despite the reported benefits of telerehabilitation, it is necessary to study its impact on the healthcare system. Methods: The systematic review aims to investigate the costs and results of telerehabilitation in neurological and cardiological diseases. MEDLINE and EMBASE databases were searched from 2005 to 2021, for studies that assess the costs and results of telerehabilitation compared to traditional rehabilitation (center-based programs) in neurological and cardiological diseases. A narrative synthesis of results was carried out. Results: A total of 8 studies (865 participants) of 430 records were included. Three studies were related to the costs and results of telerehabilitation in neurological diseases (specifically in stroke). In total, five studies assessed telerehabilitation in cardiological diseases (chronic heart failure, coronary heart disease, acute coronary syndrome, and cardiovascular diseases). The duration of the telerehabilitation ranged from 6 to 48 weeks. The studies included cost-analysis, cost-benefit, cost-effectiveness, or cost-utility. In total, four studies found significant cost/savings per person between $565.66 and $2,352.00 ( Discussion: Telerehabilitation is an excellent alternative to traditional center rehabilitation, which increases the accessibility to rehabilitation to more people, either due to the geographical situation of the patients or the limitations of the health systems. Telerehabilitation seems to be as clinical and cost-effective as traditional rehabilitation, even if, generally, telerehabilitation is less costly. More research is needed to evaluate health-related quality of life and cost-effectiveness in other neurological diseases. Systematic review registration: [https://figshare.com/articles/journal_ contribution/Review_Protocol_Costs_and_effects_of_Telerehabilitation_in_ Neurological_and_Cardiological_Diseases_A_Systematic_Review/19619838], identifier [19619838].

Indexed as

cardiological diseasescost-effectivenessneurological diseasesystematic reviewtelerehabilitation

Identifiers

PMID36523783
PMCPMC9745081
OpenAlexW4310207262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.